Are you interested measuring the amount of monoclonal antibodies in human serum?
We offer you nSmol: a sample preparation allowing to decrease the sample complexity before LC/MS quantitation of monoclonal antibodies. This method used a limited sample volume (5µL) and is suitable for clinical application.
We have already optimized nSmol(1,2) for: infliximab, adalimumab, ustekinumab, golimumab, eculizumab, etanercept, abatacept, tocilizumab, mepolizumab, cetuximab, trastuzumab, bevacizumab, cetuximab, rituximab, nivolumab, ipilimumab, ramucilumab, brentuximab and vedotin.
Contact us by phone on 04 67 33 04 22 or 04 67 33 71 73,
and by email c-hirtz@chu-montpellier.fr